Snehanshu Chowdhury

About

Post-doctoral research fellow at Massachusetts General Hospital (Affiliated under Harvard Medical School)

Worked as CSIR-Senior Research Fellow in CSIR-India Institute of Chemical Biology

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• Supplementary Data from Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8+ T Cells
  2025 DOI: 10.1158/0008-5472.30698924
  +Save
• Table S1 from Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8+ T Cells
  2025 DOI: 10.1158/0008-5472.30698921
  +Save
• Table S2 and S3 from Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8+ T Cells
  2025 DOI: 10.1158/0008-5472.30698918
  +Save
• CD38-mediated metabolic reprogramming promotes the stability and suppressive function of regulatory T cells in tumor
  Science Advances 2025 DOI: 10.1126/sciadv.adt2117
  +Save
• CD38-RyR2 axis-mediated signaling impedes CD8+ T cell response to anti-PD1 therapy in cancer.
  Proceedings of the National Academy of Sciences of the United States of America 2024 DOI: 10.1073/pnas.2315989121
  +Save
• Intratumoral PD1+CD38+Tim3+ CD8+ T Cells in Pre-BCG Tumor Tissues Are Associated with Poor Responsiveness to BCG Immunotherapy in Patients with Non-Muscle Invasive Bladder Cancer
  Cells 2023 DOI: 10.3390/cells12151939
  +Save
• Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8+ T Cells
  Cancer Research 2022 DOI: 10.1158/0008-5472.CAN-21-4052
  +Save